Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Anti-inflammatory therapy for tendinopathy using Il1rn mRNA encapsulated in SM102 lipid nanoparticles

ABSTRACT:

SUBMITTER: Zhang Y

PROVIDER: S-EPMC12378938 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

Enhanced epigenetic modulation via mRNA-encapsulated lipid nanoparticles enables targeted anti-inflammatory control.

Project description: Not available

| S-EPMC11888353 | biostudies-literature

Protocol for in vitro transfection of mRNA-encapsulated lipid nanoparticles.

Project description: Not available

| S-EPMC12597280 | biostudies-literature

Lipid-mRNA nanoparticles landscape for cancer therapy.

Project description: Not available

| S-EPMC9659646 | biostudies-literature

Circular RNA vectors encapsulated in lipid nanoparticles for sustained protein replacement therapy in the retina

Project description:Circular RNAs (circRNAs) have recently emerged as promising vectors for sustained therapeutic protein production due to their enhanced stability from exonuclease degradation. Here, we engineered circRNAs expressing reporters and neurotrophic factors, and systematically compared their expression kinetics to conventional linear mRNAs. CircRNAs achieved 10-20 fold higher and more persistent protein expression in vitro over several weeks. We further demonstrated that circRNA-expressed nerve growth factor (NGF) provided lasting neuroprotection in a neuronal injury model compared to short-lived effects from NGF protein delivery. A major challenge for clinical translation of circRNAs is efficient intracellular delivery. We address this issue through lipid nanoparticle (LNP) encapsulation technology. LNPs successfully delivered circRNAs to retina after intravitreal or subretinal injection in mice, achieving localized and prolonged expression. As proof-of-concept, LNP-formulated circRNA expressing NGF promoted retinal ganglion cell survival in a mouse optic nerve crush injury model, demonstrating advantages over NGF protein injections. Collectively, this work establishes circRNA vectors as promising candidates for safe, sustained therapeutic protein production, and elucidates a delivery platform to overcome translational barriers. Realization of this technology may enable transformative treatments for chronic neurodegenerative protein deficiency diseases.

2024-08-16 | GSE243992 | GEO

Fabrication of mRNA encapsulated lipid nanoparticles using state of the art SMART-MaGIC technology and transfection in vitro.

Project description: Not available

| S-EPMC11442764 | biostudies-literature

Safer non-viral DNA delivery using lipid nanoparticles loaded with endogenous anti-inflammatory lipids.

Project description: Not available

| S-EPMC12235526 | biostudies-literature

Genetically engineered transfusable platelets using mRNA lipid nanoparticles.

Project description: Not available

| S-EPMC10691771 | biostudies-literature

Delivery of mRNA to platelets using lipid nanoparticles.

Project description: Not available